Showing 2 posts of 2 posts found.
Valeant Pharmaceuticals has published its results for the first quarter, which has seen the firm post a net loss of …
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant